# CLARISCAN
> **ANDA210016** · Abbreviated New Drug Application (Generic) · Sponsor: GE HEALTHCARE · Approved 2019-11-01
## Drug
- **FDA Application Number:** ANDA210016
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLARISCAN
- **Generic name:** GADOTERATE MEGLUMINE
- **Active ingredients:** GADOTERATE MEGLUMINE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GE HEALTHCARE
- **Manufacturer:** GE Healthcare
- **First approval:** 2019-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210016)
---
*MORVS · CC0 1.0*